Studies showing that further immunocompromising mice using whole body irradiation, antibodies targeting NK cells, genetic manipulation to decrease immunity (e.g. NOD-SCID-β2m-deficient or NOD-SCID-IL-2Rγ-deficient mice) leads to more effective tumour growth [12]. The gene discussed is B2M; the disease is neoplasm.